Last SFr.832.50 CHF
Change Today +3.50 / 0.42%
Volume 14.6K
GALN On Other Exchanges
Symbol
Exchange
SIX Swiss Ex
OTC US
Frankfurt
OTC US
As of 12:52 PM 04/17/14 All times are local (Market data is delayed by at least 15 minutes).

Executive Profile*

Kurt W. Briner

Director, Chairman of Nominating & Corporate Governance Committee and Member of Compensation Committee, BioAmber Inc.
AgeTotal Calculated CompensationThis person is connected to 14 board members in 2 different organizations across 4 different industries.

See Board Relationships
69$45,000

Background*

Mr. Kurt W. Briner served as President and Chief Executive Officer of Sanofi Pharma S.A. in Geneva, Switzerland from 1988 to 2000. Mr. Briner has nearly 31 years of experience in the pharmaceutical industry. Mr. Briner served as the Chairman at BioAmber Inc., from 2009 to February 2012 and has been its Director since 2009. He has been a Director of Galenica Ltd. since 2004. Mr. Briner serves as a Director of Novo Nordisk Danmark and Altana Pharma. He served as a Director ...

Read Full Background

Corporate Headquarters*

Untermattweg 8
Bern, Bern 3027

Switzerland

Phone: 41 58 852 81 11
Fax: 41 58 852 81 12

Board Members Memberships*

Director
1998-2013
Former Director
2000-N/A
Former Director
2004-Present
Director
2009-Present
Director, Chairman of Nominating & Corporate Governance Committee and Member of Compensation Committee

Education*

There is no Education data available.

Other Affiliations*

Annual Compensation*

There is no Annual Compensation data available.

Stock Options*

Exercisable Options36,750
Unexercisable Options8,750
Total Number of Options45,500

Total Compensation*

Total Annual Cash Compensation$45,000
Total Calculated Compensation$45,000
*Data is at least as current as the most recent Definitive Proxy.
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
GALN:SW SFr.832.50 CHF +3.50

COMPETITOR COMPENSATION

There is no Competitor Compensation data available.

Post a JobJobs

View all jobs

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact GALENICA AG-REG, please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.